Anti-PD-1 Autoantibody Predicts Survival of Patients With Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab.
Sasaki Y, Matsumoto K, Takaki A, Adachi T, Takahara M, Ozato K, Takeuchi Y, Sue M, Miyake N, Wada N, Onishi H, Shiraha H, Oda T, Tsutsumi K, Nouso K, Kariyama K, Hagihara H, Moriya A, Otsuka M.
Sasaki Y, et al. Among authors: takeuchi y.
Gastro Hep Adv. 2024 Aug 2;3(8):1138-1147. doi: 10.1016/j.gastha.2024.07.018. eCollection 2024.
Gastro Hep Adv. 2024.
PMID: 39559295
Free PMC article.